XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.2
Stockholders’ Equity (Details)
 3 Months Ended 6 Months Ended
Jun. 06, 2023
USD ($)
$ / shares
shares
Apr. 14, 2023
USD ($)
$ / shares
shares
Feb. 17, 2023
USD ($)
$ / shares
shares
Jan. 31, 2023
USD ($)
Jul. 27, 2022
USD ($)
$ / shares
shares
Apr. 25, 2022
USD ($)
May 17, 2021
USD ($)
$ / shares
shares
Nov. 11, 2020
USD ($)
$ / shares
shares
Feb. 19, 2020
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
class_of_stock
$ / shares
shares
Jun. 30, 2023
USD ($)
class_of_stock
$ / shares
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2022
$ / shares
shares
Stockholders' Equity [Line Items]                          
Number of classes of stock | class_of_stock                   2 2    
Authorized capital stock (in Shares)                     101,000,000    
Common stock, shares authorized                   100,000,000 100,000,000   100,000,000
Common stock par value (in Dollars per share) | $ / shares                   $ 0.0001 $ 0.0001   $ 0.0001
Preferred stock, shares authorized                   1,000,000 1,000,000    
Preferred stock par value (in Dollars per share) | $ / shares                   $ 0.0001 $ 0.0001    
Amount of purchase | $         $ 14,000,000                
Sale price (in Dollars per share) | $ / shares             $ 50.00            
Proceeds from common stock offering, net of offering costs | $                     $ 781,624 $ 1,859,685  
Net proceeds from offering | $         $ 13,100,000                
Warrants outstanding, term             10 years            
Purchase agreement, authorized amount | $             $ 250,000,000            
Grant date fair value of securities purchase agreement | $             $ 12,600,000            
Unit Purchase Option                          
Stockholders' Equity [Line Items]                          
Shares issued (in Dollars per share) | $ / shares                 $ 100        
Exercisable units (in shares)                 316,250        
Options exercisable (in Dollars per share) | $ / shares                 $ 11.50        
Aggregate exercise price | $                 $ 3,636,875        
Number of shares included in a unit (in shares)                 1.1        
Unit Purchase Option | Minimum                          
Stockholders' Equity [Line Items]                          
Right to registration, period                 5 years        
Unit Purchase Option | Maximum                          
Stockholders' Equity [Line Items]                          
Right to registration, period                 7 years        
Investor                          
Stockholders' Equity [Line Items]                          
Common stock shares purchase (in Shares)               1,425,000          
Purchase price per share value (in Dollars per share) | $ / shares               $ 10.00          
Aggregate purchase price of common stock (in Dollars) | $               $ 14,250,000          
Stonepeak/Evolve Warrants - series B                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares)             2,000,000            
Exercise price (in Dollars per share) | $ / shares             $ 10.00            
Stonepeak/Evolve Warrants - series C                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares)             1,000,000            
Exercise price (in Dollars per share) | $ / shares             $ 15.00            
Percent of warrants vested upon issuance             50.00%            
Percent of warrants vested upon additional capital expenditures             50.00%            
Additional capital expenditure to trigger exercise of nonvested warrants | $             $ 125,000,000            
Stonepeak/Evolve Warrants - series D                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares)             1,000,000            
Exercise price (in Dollars per share) | $ / shares             $ 20.00            
Percent of warrants vested upon issuance             50.00%            
Percent of warrants vested upon additional capital expenditures             50.00%            
Additional capital expenditure to trigger exercise of nonvested warrants | $             $ 250,000,000            
Stonepeak/Evolve Warrants - series E                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares)             1,000,000            
Exercise price (in Dollars per share) | $ / shares             $ 30.00            
Percent of warrants vested upon issuance             50.00%            
Percent of warrants vested upon additional capital expenditures             50.00%            
Additional capital expenditure to trigger exercise of nonvested warrants | $             $ 375,000,000            
Stonepeak/Evolve Warrants - series F                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares)             1,000,000            
Exercise price (in Dollars per share) | $ / shares             $ 40.00            
Percent of warrants vested upon issuance             50.00%            
Percent of warrants vested upon additional capital expenditures             50.00%            
Additional capital expenditure to trigger exercise of nonvested warrants | $             $ 500,000,000            
Option vesting period             180 days            
PIPE warrants                          
Stockholders' Equity [Line Items]                          
Sale of units (in Shares)               1.9          
Sale price (in Dollars per share) | $ / shares               $ 11.50          
Percent of one share of common stock                 50.00%        
Stonepeak                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued             90.00%            
Evolve                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued             10.00%            
Common Stock                          
Stockholders' Equity [Line Items]                          
Common stock par value (in Dollars per share) | $ / shares         $ 0.0001                
Sale of units (in Shares)         2,150,000                
Prefunded Warrant                          
Stockholders' Equity [Line Items]                          
Number of securities called by warrants (in shares)         1,850,000                
Class of warrant or right, number of securities called by each warrant         1                
Warrants or rights exercisable term         5 years                
Warrants                          
Stockholders' Equity [Line Items]                          
Sale of units (in Shares)                 5,750,000        
Number of securities called by warrants (in shares)         4,000,000                
Exercise price (in Dollars per share) | $ / shares         $ 3.75                
Stonepeak/Evolve Warrants - series B                          
Stockholders' Equity [Line Items]                          
Exercise price (in Dollars per share) | $ / shares                   10.00 $ 10.00    
Warrants outstanding, grant date fair value | $             $ 12,800,000            
Stonepeak/Evolve Warrants - series C                          
Stockholders' Equity [Line Items]                          
Exercise price (in Dollars per share) | $ / shares                   15.00 15.00    
Warrants outstanding, grant date fair value | $             5,600,000            
Stonepeak/Evolve Warrants - series D                          
Stockholders' Equity [Line Items]                          
Exercise price (in Dollars per share) | $ / shares                   20.00 20.00    
Warrants outstanding, grant date fair value | $             4,800,000            
Stonepeak/Evolve Warrants - series E                          
Stockholders' Equity [Line Items]                          
Exercise price (in Dollars per share) | $ / shares                   30.00 30.00    
Warrants outstanding, grant date fair value | $             3,800,000            
Stonepeak/Evolve Warrants - series F                          
Stockholders' Equity [Line Items]                          
Exercise price (in Dollars per share) | $ / shares                   $ 40.00 40.00    
Warrants outstanding, grant date fair value | $             $ 3,200,000            
Stonepeak Warrants | Securities Purchase Agreement                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued             90.00%            
Evolve Warrants | Securities Purchase Agreement                          
Stockholders' Equity [Line Items]                          
Percent of warrants issued             10.00%            
Shelf Registration                          
Stockholders' Equity [Line Items]                          
Amount of purchase | $           $ 100,000,000              
At The Market Offering                          
Stockholders' Equity [Line Items]                          
Amount of purchase | $       $ 25,000,000                  
Agent fee percentage       3.00%                  
Placement agent fee, reimbursement amount | $       $ 50,000                  
Sale of units (in Shares)                   1,415,002      
Sale price (in Dollars per share) | $ / shares                   $ 0.63 $ 0.63    
Proceeds from common stock offering, net of offering costs | $                   $ 800,000      
Registered Direct Offering                          
Stockholders' Equity [Line Items]                          
Agent fee percentage 6.00% 6.00% 6.00%                    
Proceeds from common stock offering, net of offering costs | $ $ 1,000,000 $ 1,000,000 $ 500,000                    
Per unit price (in Dollars per share) | $ / shares $ 0.40 $ 0.55 $ 0.92                    
Registered Direct Offering | Common Stock                          
Stockholders' Equity [Line Items]                          
Sale of units (in Shares) 2,492,530 1,818,181 543,478                    
IPO | Newborn                          
Stockholders' Equity [Line Items]                          
Class of warrant or right, number of securities called by each warrant                 1        
Number of warrants per unit (in Shares)                 1        
Private Placement | Newborn                          
Stockholders' Equity [Line Items]                          
Number of warrants per unit (in Shares)                 1        
Private Placement | Warrants                          
Stockholders' Equity [Line Items]                          
Aggregate share purchase (in Shares)                 272,500